$ADPT filed an 8-K with results (Item 2.02) at 4:15 PM ET on Wed, Nov 4.
Vote
ADPT
Adaptive Biotechnologies CorporationAbout ADPT
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.
Why it moved
Moved with Biotech peers: MRNA +13.10% · VCEL +10.67% · PCVX +7.90%
From market data · Not investment advice
Why it moved
Moved with Biotech peers: MRNA +13.10% · VCEL +10.67% · PCVX +7.90%
From market data: the larger companies in its group moved the same way. No report names a cause yet.
Last check 7:30 PM ET
From market data · Not investment adviceSign up free to see this.
Analysts
All ›Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
Sentiment
No sentiment yet
Votes and Bull · Bear posts, 24h. At least 5 are needed.
How do you feel about ADPT?
Board · 0 threads
Open board ›Community opinions, not advice. Posts with a target get a receipt. How receipts work ›